Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2008

Study Completion Date

June 30, 2014

Conditions
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Interventions
DRUG

vatalanib

Pts registered before 1/15/05 1250 mg/day PO After 1/15/05: Start w/ 750 mg/day PO; escalate q 4 wks in absence of Grade 2 or \> tox (1st increase=1000mg/day; 2nd increase 1250 mg/day)

Trial Locations (68)

10029

Mount Sinai Medical Center, New York

11030

Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset

11042

Long Island Jewish Medical Center, New Hyde Park

13210

SUNY Upstate Medical University Hospital, Syracuse

Veterans Affairs Medical Center - Syracuse, Syracuse

13502

Faxton Regional Cancer Center, Utica

19713

CCOP - Christiana Care Health Services, Newark

19958

Tunnell Cancer Center at Beebe Medical Center, Lewes

21921

Union Hospital Cancer Program at Union Hospital, Elkton MD

24541

Danville Regional Medical Center, Danville

27534

Wayne Memorial Hospital, Incorporated, Goldsboro

27710

Duke Comprehensive Cancer Center, Durham

28501

Kinston Medical Specialists, Kinston

28791

Pardee Memorial Hospital, Hendersonville

33140

CCOP - Mount Sinai Medical Center, Miami Beach

33308

Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale

33458

Ella Milbank Foshay Cancer Center at Jupiter Medical Center, Jupiter

46515

Elkhart General Hospital, Elkhart

46601

CCOP - Northern Indiana CR Consortium, South Bend

Memorial Hospital of South Bend, South Bend

46815

Fort Wayne Medical Oncology and Hematology, Fort Wayne

49085

Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph

55417

Veterans Affairs Medical Center - Minneapolis, Minneapolis

61108

Center for Cancer Care at OSF Saint Anthony Medical Center, Rockford

61350

Community Hospital of Ottawa, Ottawa

Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa

61354

Illinois Valley Community Hospital, Peru

61356

Perry Memorial Hospital, Princeton

61362

St. Margaret's Hospital, Spring Valley

61401

Galesburg Clinic, PC, Galesburg

Galesburg Cottage Hospital, Galesburg

61455

McDonough District Hospital, Macomb

61520

Graham Hospital, Canton

61530

Eureka Community Hospital, Eureka

61554

Cancer Treatment Center at Pekin Hospital, Pekin

61614

Proctor Hospital, Peoria

61615

CCOP - Illinois Oncology Research Association, Peoria

Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria

61636

Methodist Medical Center of Illinois, Peoria

61747

Hopedale Medical Complex, Hopedale

61761

BroMenn Regional Medical Center, Normal

Community Cancer Center, Normal

62321

Memorial Hospital, Carthage

62644

Mason District Hospital, Havana

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

64131

CCOP - Kansas City, Kansas City

65203

Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

68114

Methodist Estabrook Cancer Center, Omaha

68122

Immanuel Medical Center, Omaha

68124

Alegant Health Cancer Center at Bergan Mercy Medical Center, Omaha

69103

Callahan Cancer Center at Great Plains Regional Medical Center, North Platte

73104

Oklahoma University Cancer Institute, Oklahoma City

73120

Cancer Care Associates - Mercy Campus, Oklahoma City

60201-1781

Evanston Northwestern Healthcare - Evanston Hospital, Evanston

04240

Central Maine Comprehensive Cancer Center at Central Maine Medical Center, Lewiston

68131-2197

Creighton University Medical Center, Omaha

68198-6805

UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

28233-3549

Presbyterian Cancer Center at Presbyterian Hospital, Charlotte

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

15224-1791

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh

02903

Rhode Island Hospital Comprehensive Cancer Center, Providence

02906

Miriam Hospital, Providence

05602

Mountainview Medical, Berlin Corners

05401

Fletcher Allen Health Care - University Health Center Campus, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00072475 - Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes | Biotech Hunter | Biotech Hunter